KIMBERLY MYERS: Open Payments
NPI 1396339487 · EUCLID, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,215 in 62 payments from 16 companies in 2025. Trend: 2023 $698 · 2024 $1,348 · 2025 $1,215
Food & beverage: $1,215
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $386 |
| ABBVIE INC. | 11 | $184 |
| Novo Nordisk Inc | 6 | $113 |
| Dexcom, Inc. | 3 | $70 |
| Boston Scientific Corporation | 2 | $61 |
| PFIZER INC. | 3 | $55 |
| Exact Sciences Corporation | 3 | $54 |
| Amgen Inc. | 3 | $52 |
| Corcept Therapeutics | 3 | $51 |
| GlaxoSmithKline, LLC. | 3 | $49 |
Products named: AIRSUPRA, VRAYLAR, Dexcom G6 Transmitter, FARXIGA, WaveWriter Alpha Prime 16, Cologuard Collection Kit, REPATHA, Korlym.
Industry payments across OH — which companies pay providers there.
